839: Phase II Trial of Intravesical Gemcitabine in BCG-Refractory Transitional Cell Carcinoma of the Bladder
- 1 April 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 175 (4), 270-271
- https://doi.org/10.1016/s0022-5347(18)33075-1